Deutsche Bank Aktiengesellschaft Boosts Danaher (NYSE:DHR) Price Target to $250.00

Key Points

• Deutsche Bank Aktiengesellschaft raised the price target for Danaher Corporation from $235.00 to $250.00, maintaining a "buy" rating, indicating a potential upside of 14.66% from the previous close.
• Danaher reported earnings per share (EPS) of $1.89 for its last quarter, surpassing analysts' expectations of $1.72, with revenue reaching $6.05 billion.
• The stock's consensus target price among analysts stands at $248.92, with a majority rating of "buy" from 18 out of 24 analysts.

Danaher (NYSE:DHR - Get Free Report) had its price objective hoisted by Deutsche Bank Aktiengesellschaft from $235.00 to $250.00 in a research note issued to investors on Wednesday,MarketScreener reports. The firm presently has a "buy" rating on the conglomerate's stock. Deutsche Bank Aktiengesellschaft's target price points to a potential upside of 14.66% from the company's previous close.

A number of other research analysts have also recently commented on DHR. Guggenheim restated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. UBS Group reduced their price target on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Barclays boosted their price target on Danaher from $225.00 to $250.00 and gave the stock an "overweight" rating in a report on Wednesday. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Finally, Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. Eighteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $248.92.

Danaher Price Performance

Shares of NYSE DHR traded down $2.74 during mid-day trading on Wednesday, reaching $218.03. The company had a trading volume of 560,296 shares, compared to its average volume of 4,235,630. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher has a one year low of $171.00 and a one year high of $260.88. The firm has a market cap of $156.12 billion, a price-to-earnings ratio of 46.39, a PEG ratio of 3.01 and a beta of 0.77. The business's 50-day simple moving average is $202.07 and its 200 day simple moving average is $197.59.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts' consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $6.05 billion for the quarter, compared to analysts' expectations of $6 billion. During the same quarter last year, the business earned $1.71 earnings per share. Danaher's revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts predict that Danaher will post 7.63 earnings per share for the current fiscal year.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Danaher

Institutional investors have recently modified their holdings of the company. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the last quarter. WFA of San Diego LLC purchased a new stake in Danaher in the 2nd quarter valued at $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the 2nd quarter valued at $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher in the 3rd quarter valued at $28,000. Finally, Sierra Ocean LLC raised its position in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.